Simethicone as Part of ERAS in Bariatric Surgery Patients
NCT06812832
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Simethicone
- Bariatric Surgery
- Post-operative Pain
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 to 89 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Madigan Army Medical Center
- Last updated on ClinicalTrials.gov
- June 15, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Washington · 1
- Madigan Army Medical Center · Tacoma, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.